Release Date: 30/12/22 19:47 Summary: Final Distribution Announcement Price Sensitive: Yes Download Document 221.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%